Raptor Pharma (RPTP) Tops Q3 EPS by 14c

Raptor Pharma (NASDAQ: RPTP) reported Q3 EPS of ($0.04), $0.14 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $23.8 million versus the consensus estimate of $18.9 million.

For earnings history and earnings-related data on Raptor Pharma (RPTP) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• SanDisk upgraded at JPMorgan after investor day; shares climb